<bill session="117" type="s" number="5002" updated="2023-11-09T20:44:26Z">
  <state datetime="2022-09-29">PASS_OVER:SENATE</state>
  <status>
    <unknown datetime="2022-09-29"/>
  </status>
  <introduced datetime="2022-09-29"/>
  <titles>
    <title type="display">FDA Modernization Act 2.0</title>
    <title type="short" as="passed senate">FDA Modernization Act 2.0</title>
    <title type="short" as="introduced">FDA Modernization Act 2.0</title>
    <title type="official" as="introduced">A bill to allow for alternatives to animal testing for purposes of drug and biological product applications.</title>
  </titles>
  <sponsor bioguide_id="P000603"/>
  <cosponsors>
    <cosponsor bioguide_id="B001288" joined="2022-09-29"/>
    <cosponsor bioguide_id="B001310" joined="2022-09-29"/>
    <cosponsor bioguide_id="C001035" joined="2022-09-29"/>
    <cosponsor bioguide_id="C000880" joined="2022-09-29"/>
    <cosponsor bioguide_id="K000383" joined="2022-09-29"/>
    <cosponsor bioguide_id="L000570" joined="2022-09-29"/>
    <cosponsor bioguide_id="M001198" joined="2022-09-29"/>
    <cosponsor bioguide_id="P000145" joined="2022-09-29"/>
    <cosponsor bioguide_id="S000033" joined="2022-09-29"/>
    <cosponsor bioguide_id="S001217" joined="2022-09-29"/>
    <cosponsor bioguide_id="T000278" joined="2022-09-29"/>
  </cosponsors>
  <actions>
    <action datetime="2022-09-29">
      <text>Introduced in Senate</text>
    </action>
    <vote how="by Unanimous Consent" type="vote" datetime="2022-09-29" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.</text>
      <reference ref="CR S5514-5515" label="consideration"/>
      <reference ref="CR S5514-5515" label="text"/>
    </vote>
    <action datetime="2022-09-29">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2022-09-29T15:59:44-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2022-09-29T18:51:15-04:00">
      <text>Held at the desk.</text>
    </action>
  </actions>
  <committees/>
  <relatedbills>
    <bill session="117" type="s" number="4348" relation="unknown"/>
    <bill session="117" type="s" number="4288" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Animal protection and human-animal relationships"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2022-11-04T10:54:07Z" status="Passed Senate">FDA Modernization Act 2.0

This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.

The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.</summary>
</bill>
